Delcath Systems (DCTH) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.31% |
| Dec 31, 2025 | 38.18% |
| Sep 30, 2025 | 103.68% |
| Jun 30, 2025 | 68.62% |
| Mar 31, 2025 | 64.44% |
| Dec 31, 2024 | 66.55% |
| Sep 30, 2024 | 19.68% |
| Jun 30, 2024 | 16.45% |
| Mar 31, 2024 | 21.20% |
| Dec 31, 2023 | 25.04% |
| Sep 30, 2023 | 47.92% |
| Jun 30, 2023 | 54.98% |
| Mar 31, 2023 | -16.08% |
| Dec 31, 2022 | -60.47% |
| Sep 30, 2022 | -23.18% |
| Jun 30, 2022 | -39.50% |
| Mar 31, 2022 | 61.29% |
| Dec 31, 2021 | 58.56% |
| Sep 30, 2021 | 21.19% |
| Jun 30, 2021 | 22.79% |
| Mar 31, 2021 | 20.55% |
| Dec 31, 2020 | 20.75% |
| Sep 30, 2020 | -24.68% |
| Jun 30, 2020 | -10.09% |
| Mar 31, 2020 | -19.99% |
| Dec 31, 2019 | -18.64% |
| Sep 30, 2019 | -23.82% |
| Jun 30, 2019 | -26.04% |
| Mar 31, 2019 | -22.88% |
| Dec 31, 2018 | -20.08% |
| Sep 30, 2018 | -16.81% |
| Jun 30, 2018 | -19.10% |
| Mar 31, 2018 | -16.67% |
| Dec 31, 2017 | -49.18% |
| Sep 30, 2017 | -15.71% |
| Jun 30, 2017 | -47.39% |
| Mar 31, 2017 | -15.27% |
| Dec 31, 2016 | -15.52% |
| Sep 30, 2016 | -35.60% |
| Jun 30, 2016 | -25.90% |
| Dec 31, 2015 | -21.62% |